VYNE Therapeutics (VYNE) CLO has shares withheld for RSU taxes

Rhea-AI Filing Summary

VYNE Therapeutics Inc.’s chief legal officer Mutya Harsch reported a tax-withholding share disposition. The issuer withheld 22,516 shares of common stock on July 23, 2026 at $0.8976 per share to satisfy tax obligations on vested restricted stock units. Harsch now directly holds 95,918 shares.

Insider Trade Summary

Net Seller: 22,516 shares

Net Sell 1 txn

Insider Harsch Mutya

Role CHIEF LEGAL OFFICER AND GC

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	22,516	$0.8976	$20K

Holdings After Transaction: Common Stock — 95,918 shares (Direct)

Footnotes (1)

1. F1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Key Figures

Shares withheld for taxes: 22,516 shares Per-share value for tax withholding: $0.8976 per share Shares held after transaction: 95,918 shares

3 metrics

Shares withheld for taxes 22,516 shares Common stock withheld on July 23, 2026 to satisfy tax withholding on RSU vesting

Per-share value for tax withholding $0.8976 per share Value applied to the 22,516-share tax-withholding disposition

Shares held after transaction 95,918 shares Direct common stock holdings of Mutya Harsch following the tax-withholding transaction

Key Terms

restricted stock units, tax withholding requirements, tax-withholding disposition

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding requirements financial

"withheld by the Issuer to satisfy tax withholding requirements"

tax-withholding disposition financial

"transaction_action":"tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/24/2026 - 05:00 PM Accepted by SEC EDGAR 07/24/2026 - 05:00 PM Learn about SEC filing dates

FAQ

What insider transaction did VYNE (VYNE) report for Mutya Harsch?

VYNE’s chief legal officer Mutya Harsch reported a tax-withholding share disposition. The issuer withheld shares of common stock to cover tax obligations arising from the vesting of restricted stock units, rather than executing an open-market sale.

How many VYNE (VYNE) shares were withheld for taxes in this Form 4?

The issuer withheld 22,516 shares of VYNE Therapeutics common stock. These shares were used to satisfy tax withholding requirements connected to the vesting of restricted stock units, as indicated in the filing’s explanatory footnote.

At what price were the withheld VYNE (VYNE) shares valued?

The withheld shares were valued at $0.8976 per share. This per-share amount applies to the 22,516 shares withheld to cover tax obligations linked to the vesting of restricted stock units for chief legal officer Mutya Harsch.

How many VYNE (VYNE) shares does Mutya Harsch hold after this transaction?

After the tax-withholding transaction, Mutya Harsch directly holds 95,918 shares of VYNE common stock. This figure reflects her post-transaction direct ownership as reported in the Form 4’s non-derivative holdings section.

Was the VYNE (VYNE) Form 4 transaction a market sale of shares?

No, the transaction was a tax-withholding disposition, not an open-market sale. Shares were withheld by the issuer to satisfy tax withholding requirements related to restricted stock unit vesting, according to the transaction code F and accompanying footnote.

What triggered the tax-withholding share disposition reported by VYNE (VYNE)?

The disposition was triggered by the vesting of restricted stock units held by Mutya Harsch. To meet associated tax withholding requirements, the issuer withheld 22,516 shares of common stock instead of requiring a separate cash payment for the taxes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harsch Mutya

(Last) (First) (Middle)

C/O VYNE THERAPEUTICS INC.

P.O. BOX 125

(Street)

STEWARTSVILLE NEW JERSEY 08886

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VYNE Therapeutics Inc. [ VYNE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF LEGAL OFFICER AND GC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/23/2026		F(1)		22,516	D	$0.8976	95,918	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

	/s/ Mutya Harsch	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)